Cargando…
Exome sequencing reveals a potential mutational trajectory and treatments for a specific pancreatic cancer patient
Pancreatic cancer is the fourth biggest killer, and has one of the worst prognoses, of any cancer type. Approximately 95% of patients diagnosed with pancreatic cancer will not survive beyond 5 years post diagnosis, and these statistics have barely improved in over 40 years. Here, genomic changes in...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014375/ https://www.ncbi.nlm.nih.gov/pubmed/24833909 http://dx.doi.org/10.2147/OTT.S45232 |